Pulak Kumar Metia

Title: Pulak Kumar Metia: Innovator in Pharmaceutical Composition

Introduction

Pulak Kumar Metia is a notable inventor based in Howrah, India. He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His work focuses on developing innovative pharmaceutical compositions that enhance the efficacy and usability of medications.

Latest Patents

Among his latest patents is a multi-particulate pharmaceutical composition of quetiapine. This invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each containing quetiapine or a pharmaceutically acceptable salt thereof along with one or more pharmaceutically acceptable excipients. Another significant patent is for a pharmaceutical composition of doxycycline with reduced food effect. This invention relates to a once-daily pharmaceutical composition that includes doxycycline and one or more pharmaceutically acceptable excipients, designed to exhibit a reduced food effect. The invention also provides a method for treating rosacea by administering the doxycycline pharmaceutical composition with or without food.

Career Highlights

Pulak Kumar Metia has worked with prominent companies in the pharmaceutical industry, including Sun Pharmaceutical Industries Limited and Ranbaxy Laboratories, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

He has collaborated with notable coworkers such as Romi Barat Singh and Ravish Sharma, further enhancing his contributions to the field.

Conclusion

Pulak Kumar Metia's innovative work in pharmaceutical compositions demonstrates his commitment to improving medication efficacy and patient care. His patents reflect a deep understanding of pharmaceutical science and a dedication to advancing healthcare solutions.